Interview with the Innovators

Interview with the Innovators

New treatments for multiple myeloma have brought hope to many patients and their families. However, some patients do not remain adherent to their therapy. Join our experts, Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they discuss how they help patients understand the importance of remaining on their therapy.
Helping the patient’s caregiver understand their role in the NSCLC patient’s journey
Addressing common questions from NSCLC patients and their caregivers
Providing psychosocial support and counseling for NSCLC patients and their family
Educating patients about cancer- and treatment-related side effect management
Identification of new actionable targets and driver mutations have revolutionized the treatment of NSCLC
Waiting for biomarker test results ensures the best outcomes in NSCLC.
Describing the road map of the cancer care journey in NSCLC.
The use of targeted agents and immunotherapy has transformed the treatment of NSCLC
Encouraging shared decision making by NSCLC by educating and counseling patients and their families
Page 2 of 4
Results 11 - 20 of 33